

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| Human neutrophils | 250 nM | at least 30 min | To evaluate the effect of Avacopan on neutrophil chemotaxis, results showed that Avacopan significantly inhibited C5a-induced neutrophil chemotaxis. | Front Immunol. 2021 Nov 24;12:777932 |
| monocytes | 10 µM | 15 min | To evaluate the inhibitory effect of Avacopan on PVL-induced inflammasome activation in monocytes, results showed that Avacopan significantly reduced IL-1β secretion | Med Microbiol Immunol. 2024 Sep 19;213(1):19 |
| polymorphonuclear neutrophils (PMNs) | 1 µM to 10 µM | 15 min | To evaluate the inhibitory effect of Avacopan on PVL-induced cytotoxicity in PMNs, results showed that Avacopan significantly increased the EC50 of PVL, indicating its inhibitory effect on PVL cytotoxicity | Med Microbiol Immunol. 2024 Sep 19;213(1):19 |
| Administration | Dosage | Frequency | Description | References | ||
| MRL/lpr mice | Murine model of spontaneous lupus nephritis | Oral gavage | 30 mg/kg | Once daily for two weeks | Avacopan reduced granulocyte infiltration and improved renal function in MRL/lpr mice | EBioMedicine. 2021 Aug;70:103477 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.72mL 0.34mL 0.17mL |
8.60mL 1.72mL 0.86mL |
17.19mL 3.44mL 1.72mL |
|
| CAS号 | 1346623-17-3 |
| 分子式 | C33H35F4N3O2 |
| 分子量 | 581.64 |
| SMILES Code | O=C([C@@H]1[C@H](C2=CC=C(NC3CCCC3)C=C2)N(C(C4=C(C)C=CC=C4F)=O)CCC1)NC5=CC=C(C)C(C(F)(F)F)=C5 |
| MDL No. | MFCD28502293 |
| 别名 | CCX168 |
| 运输 | 蓝冰 |
| InChI Key | PUKBOVABABRILL-YZNIXAGQSA-N |
| Pubchem ID | 49841217 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 9 mg/mL(15.47 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1